KING INTERNATIONAL INVESTMENT LIMITED | Code: | 00928 | ||
Website: | http://www.kinginternational.hk |
Chairman | ||||||||||||||||||
Liu Mingqing 、 Wang Mengyao | ||||||||||||||||||
Business Nature | ||||||||||||||||||
Health Care | ||||||||||||||||||
Board Members | ||||||||||||||||||
Chairman | Liu Mingqing 、 Wang Mengyao | |||||||||||||||||
Executive Director: | Lu Xingwu 、 Gu Jianguo 、 Man Wai Lun 、 Pang Zhen 、 Yan Ming | |||||||||||||||||
Independent Non-executive Director: | Yang Xilin 、 Lou Tao 、 Zheng Yu 、 Wang Zhenyu | |||||||||||||||||
Main Business (This information is available in Chinese version only.) | ||||||||||||||||||
主要提供基因檢測及健康數據分析服務,亦從事借貸業務及酒類銷售業務。 | ||||||||||||||||||
Annual Report (This information is available in Chinese version only.) | ||||||||||||||||||
至2023年9月30日止 至2023年3月31日止 (千元) (六個月) 變動(%) (全年度) 變動(%) ------------------------------------------------ 營業額* 83﹐427 47﹒9 223﹐853 1﹒4倍 除稅前溢利/(虧損)* 2﹐690 - (30﹐709) - 股東應佔溢利/(虧損) 1﹐693 - (25﹐192) - ------------------------------------------------ *為持續經營業務(截至2023年9月止六個月) | ||||||||||||||||||
Major Shareholders | ||||||||||||||||||
|
Remarks: | Information provided by: etnet 經濟通 Disclaimer |